Maharah Company for Saudi Human Resources announced that its unit, Growth Path for Investment, received an unobjectionable statement from the General Competition Authority to complete the economic concentration process between the Growth Path Investment Company and Shefa Arabia Medical Company.
Mahara announced that its 100% subsidiary, Growth Path for Investment, had signed a sale and purchase agreement to acquire an 85% stake in Shefa Arabia Medical Company on December 6, 2021.
The company stressed that the closing of the transaction and the transfer of the shares are subject to regulatory approvals and that any developments will be announced. in following.
Read More About: Business News